Dry Eye Disease

TYRVAYA™(varenicline solution) Nasal Spray is approved in the US for the Treatment of the Signs and Symptoms of Dry Eye Disease

PRINCETON, N.J., October 18, 2021 Oyster Point Pharma, Inc. (Nasdaq: OYST), announced that the U.S. Food and Drug Administration (FDA) has approved TYRVAYA™ (varenicline solution) Nasal Spray 0.03 mg for the treatment of the signs and symptoms of dry eye disease. TYRVAYA Nasal Spray is the first and only nasal spray…